Vir Biotechnology (VIR) Fair Value & DCF
Score
VIR fair value $108.89. Price $9.96. Price is 91% below fair value.
Worked example
No cash-flow value. Free cash flow is not steady enough to discount.
Earnings value. Next-twelve-months earnings per share of $3.83 times 28.43 is $108.89. The peer group is Biotechnology, 13 companies worth at least $10 billion. This stock has no 10-year median P/E, so the peer median of 28.4 is kept between 8 and 30, which is 28.43.
Fair value is the earnings value, $108.89. The price is $9.96, which is 90.9% below fair value.